Is coeliac disease screening in risk groups justified? A fourteen-year follow-up with special focus on compliance and quality of life

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 4, 2005, Pages 317-324

  Viljamaa, M ^a   Collin, P ^a   Huhtala, H ^a   Sievanen H ^a   Maki M ^a   Kaukinen, K ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CELIAC DISEASE; CONTROLLED STUDY; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SCREENING; SEROLOGY; WELLBEING;

ADULT; AGED; BODY MASS INDEX; BONE DENSITY; CELIAC DISEASE; FEMALE; FRACTURES, BONE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; RISK FACTORS;

EID: 23944501253     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02574.x     Document Type: Article

References (34)

1. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 2517-24.
2. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92.
3. Greco L, Mäki M, Di Donato F, Visakorpi JK. Epidemiology of coeliac disease in Europe and the Mediterranean area. In: Auricchio S, Visakorpi JK, eds. Common Food Intolerances I: Epidemiology of Coeliac Disease. Dyn Nutr Res. Basel: Karger, 1992: 25-44.
4. Visakorpi JK, Mäki M. Changing clinical features of coeliac disease. Acta Paediatr Suppl 1994; 83: 10-3.
5. Mäki M, Collin P. Coeliac disease. Lancet 1997; 349: 1755-59.
6. Hallert C, Grännö C, Grant C, Hulten S, Midhagen G, Ström M. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol 1998; 33: 993-8.
7. Hallert C, Grännö C, Hulten S, et al. Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol 2002; 37: 39-42.
8. Mustalahti K, Lohiniemi S, Collin P, Vuolteenaho N, Laippala P, Mäki M. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 2002; 5: 105-13.
9. Fabiani E, Taccari LM, Rätsch I-M, DiGiuseppe S, Coppa GV, Catassi C. Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5-year follow-up study. J Pediatr 2000; 136: 841-3.
10. National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28-30, 2004. Gastroenterology 2005; 128: S1-S9.
11. Kumar PJ. European and North American populations should be screened for coeliac disease. Gut 2003; 52: 170-1.
12. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 52: 168-9.
13. Aalto A, Aro A, Teperi J. RAND-36 terveyteen liittyvän elämänlaadun mittarina. Mittarin luotettavuus ja suomalaiset väestöarvot. Stakes tutkimuksia 1999; 101: 1-78.
14. Sulkanen S, Collin P, Laurila K, Mäki M. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998; 33: 251-4.
15. Dimenäs E, Carlsson H, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996; 31: 8-13.
16. McHorney CA, Ware JEJ, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40-66.
17. O'Leary C, Wieneke P, Healy M, Cronin C, O'regan P, Shanahan F. Celiac disease and the transition from childhood to adulthood: a 28-year follow-up. Am J Gastroenterol 2004; 99: 2437-41.
18. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33: 129-34.
19. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75-83.
20. Sievänen H, Kannus P, Nieminen V, Heinonen A, Oja P, Vuori I. Estimation of various mechanical characteristics of human bone using dual energy X-ray absorptiometry: methodology and precision. Bone 1996; 18: 17S-27S.
21. Report of a WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994; 843: 1-129.
22. Fasano A. Celiac disease - how to handle a clinical chameleon. N Engl J Med 2003; 348: 2568-70.
23. Vuolteenaho N, Kekkonen L, Aspegren M, Kaukinen K, Mäki M, Collin P. How to detect coeliac disease: population screening or clinical work-up? 11th International Symposium on Coeliac Disease, Belfast, Northern Ireland, Abstract book, P57; 2004.
24. Hallert C, Sandlund O, Broqvist M. Perceptions of health-related quality of life of men and women living with coeliac disease. Scand J Caring Sci 2003; 17: 301-7.
25. Addolorato G, Capristo E, Ghittoni G, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scand J Gastroenterol 2001; 36: 502-6.
26. Johnston SD, Rodgers C, Watson RG. Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol 2004; 16: 1281-6.
27. Ciacci C, D'Agate C, De Rosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci 2003; 48: 2216-20.
28. Di Matteo MR, Lepper H, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Metaanalysis of the effect of anxiety and depression on patients adherence. Arch Intern Med 2000; 160: 2101-7.
29. Addolorato G, De Lorenzi G, Abenavoli L, Leggio L, Capristo E, Gasbarrini G. Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders. Aliment Pharmacol Ther 2004; 20: 777-82.
30. Mustalahti K, Collin P, Sievänen H, Salmi J, Mäki M. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet 1999; 354: 744-5.
31. Corazza GR, DiSario A, Gecchetti L, et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone 1996; 18: 525-30.
32. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002; 287: 1413-9.
33. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders and celiac disease. Endocrine Reviews 2002; 23: 464-83.
34. Locke GRR, Murray JA, Zinsmeister AR, Melton Jr L, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004; 79: 476-82.